CVS Health Co. (NYSE:CVS) Position Reduced by Creegan & Nassoura Financial Group LLC

Creegan & Nassoura Financial Group LLC reduced its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 14.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 30,377 shares of the pharmacy operator's stock after selling 5,264 shares during the period. Creegan & Nassoura Financial Group LLC's holdings in CVS Health were worth $1,364,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the stock. State of Tennessee Department of Treasury grew its holdings in CVS Health by 4.7% in the fourth quarter. State of Tennessee Department of Treasury now owns 477,251 shares of the pharmacy operator's stock valued at $21,424,000 after purchasing an additional 21,251 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in shares of CVS Health by 40.1% in the 4th quarter. Tower Research Capital LLC TRC now owns 70,218 shares of the pharmacy operator's stock worth $3,152,000 after buying an additional 20,107 shares in the last quarter. Thematics Asset Management grew its stake in CVS Health by 34.3% in the 4th quarter. Thematics Asset Management now owns 77,029 shares of the pharmacy operator's stock valued at $3,458,000 after acquiring an additional 19,653 shares during the last quarter. Trajan Wealth LLC lifted its holdings in shares of CVS Health by 10.6% in the fourth quarter. Trajan Wealth LLC now owns 65,886 shares of the pharmacy operator's stock valued at $2,958,000 after purchasing an additional 6,312 shares in the last quarter. Finally, MetLife Investment Management LLC grew its position in shares of CVS Health by 1.8% in the fourth quarter. MetLife Investment Management LLC now owns 333,134 shares of the pharmacy operator's stock valued at $14,954,000 after purchasing an additional 5,964 shares during the last quarter. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analyst Ratings Changes

CVS has been the topic of a number of recent research reports. Truist Financial upped their target price on CVS Health from $76.00 to $82.00 and gave the company a "buy" rating in a research note on Friday, April 11th. Cantor Fitzgerald upgraded CVS Health from a "neutral" rating to an "overweight" rating in a research report on Wednesday, February 12th. Wells Fargo & Company lifted their price objective on CVS Health from $68.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday, February 13th. Evercore ISI raised their price target on shares of CVS Health from $60.00 to $65.00 and gave the stock an "outperform" rating in a research note on Monday, January 27th. Finally, Piper Sandler boosted their price objective on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research report on Friday, March 21st. Four research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, CVS Health currently has an average rating of "Moderate Buy" and an average target price of $71.83.

CVS Health Stock Performance

CVS traded up $0.13 during trading hours on Wednesday, hitting $65.58. 10,832,978 shares of the stock were exchanged, compared to its average volume of 11,842,125. The stock has a 50-day simple moving average of $66.48 and a 200-day simple moving average of $58.82. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $71.45. The stock has a market cap of $82.68 billion, a price-to-earnings ratio of 17.92, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be given a $0.665 dividend. The ex-dividend date of this dividend is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a yield of 4.06%. CVS Health's dividend payout ratio is presently 72.68%.

Insider Buying and Selling at CVS Health

In other news, SVP James David Clark sold 7,513 shares of the stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total value of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares of the company's stock, valued at approximately $556,941.90. This represents a 47.23 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Michael F. Mahoney acquired 30,000 shares of the business's stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the purchase, the director now owns 39,356 shares of the company's stock, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.22% of the stock is currently owned by company insiders.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.